ORCID: https://orcid.org/0000-0002-2246-6843; Horn, Katrin
ORCID: https://orcid.org/0000-0002-5307-6936; Pott, Janne
ORCID: https://orcid.org/0000-0002-5983-5331; Delgado, Graciela E.; Kleber, Marcus E.; März, Winfried; Moissl-Blanke, Angela Patricia
ORCID: https://orcid.org/0000-0003-0302-2136; Silbernagel, Günther; Waldenberger, Melanie; Grallert, Harald; Peters, Annette
ORCID: https://orcid.org/0000-0001-6645-0985; Gieger, Christian
ORCID: https://orcid.org/0000-0001-6986-9554; Baber, Ronny; Kirsten, Holger; Loeffler, Markus; Isermann, Berend; Thiery, Joachim; Kovacs, Peter
ORCID: https://orcid.org/0000-0002-0290-5423; Tönjes, Anke; Stumvoll, Michael; Gylling, Helena; Kähönen, Mika; Lehtimäki, Terho; Mishra, Pashupati Prasad; Raitakari, Olli; Ceglarek, Uta und Scholz, Markus
ORCID: https://orcid.org/0000-0002-4059-1779
(2026):
A genome-wide association meta-analysis of cholesterol synthesis intermediates identifies three associations for lanosterol.
In: eBioMedicine, Vol. 124, 106144: p. 106144
[PDF, 2MB]
Abstract
Background: Cholesterol is a main contributor to coronary artery disease (CAD). Although the genetic basis of blood cholesterol concentration is well studied, there is currently a lack of studies investigating the genetics of its precursors from de novo biosynthesis.
Methods: We conducted a genome-wide association meta-analysis, combining data from KORA, LIFE-Heart, LIFE-Adult, LURIC, the Sorbs study, and YFS, resulting in up to 10,519 individuals. We investigated 14 traits related to serum concentrations of lanosterol, desmosterol, and cholesterol. Direct and indirect effects of lanosterol on CAD were investigated with a Mendelian randomisation mediation analysis.
Findings: Our analysis revealed four genome-wide significant (p < 5 × 10-8) associations not previously reported in the GWAS catalogue. These include two loci without prior connection to cholesterol, associated with lanosterol (7q21.2, CYP51A1) and free cholesterol (11q14.1), and two associations with lanosterol at loci previously reported for cholesterol (5q13.3, HMGCR; 11q23.3, APO cluster). We also replicated eight loci previously reported for associations with cholesterol-related traits. Lanosterol exhibited significant total and indirect effects on CAD, but its direct effect was not significant.
Interpretation: We demonstrate that the investigation of intermediate phenotypes can help to functionally fine map previously reported associations for cholesterol, improving our understanding of genetic regulation of cholesterol concentrations. Further, the effect of lanosterol on CAD is probably fully mediated by total cholesterol.
Funding: This investigation was primarily funded by the ministry for science and health of the Rhineland-Palatinate through the CoAGE graduate programme. A complete list of funding organisations is provided in the acknowledgements.
| Item Type: | Journal article |
|---|---|
| EU Funded Grant Agreement Number: | 848146 |
| Keywords: | Cholesterol biosynthesis; Coronary artery disease; Desmosterol; GWAS; Lanosterol. |
| Faculties: | Medicine > Institute for Medical Information Processing, Biometry and Epidemiology |
| Subjects: | 600 Technology > 610 Medicine and health |
| URN: | urn:nbn:de:bvb:19-epub-135149-5 |
| ISSN: | 2352-3964 |
| Language: | English |
| Item ID: | 135149 |
| Date Deposited: | 17. Apr 2026 09:53 |
| Last Modified: | 17. Apr 2026 09:53 |
| DFG: | Gefördert durch die Deutsche Forschungsgemeinschaft (DFG) - 198800877 |
